A look at how brain tumor cells resist the chemo drug cisplatin
Original title: Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of where lab research stands, not a new result or a treatment people can get.
The short version
Scientists reviewed what is known about tiny molecules inside brain tumor cells that may help those cells survive a chemo drug.
What was studied. This is a review paper. The authors gathered past lab research on malignant gliomas, a fast-growing brain tumor, and a chemo drug called cisplatin. They looked at long non-coding RNAs, which are molecules in cells that help turn genes on and off.
What they found. Several of these molecules have been linked to glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary growth and to tumors resisting treatment. They include DANCR, HOXD-AS1, MEG3, MALAT1, and HOTAIR. One of them, DANCR, has been reported to help glioma cells resist cisplatin by blocking cell death and switching on signals that keep the cells alive. The authors also list ways these molecules may work, such as changing how the drug moves in and out of cells, repairing damage to DNA, and helping tumor stem cells survive.
What this means, and what it doesn't
What it could mean: This is background science. It points to possible new targets that researchers could aim at someday, if a drug is ever built to do that. For a patient today, nothing changes. The authors say plainly that there are gaps in the evidence and real hurdles before any of this could reach the clinic.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is a review of earlier lab work, not a new study and not a trial. Nothing here was tested in people. No one has shown that changing these molecules helps a person with a brain tumor live longer or feel better. It does not mean cisplatin will start working better for anyone now, and it does not change what your doctor can offer you today.
Source: PubMed, July 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.